2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
13
Triple Negative Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Ovarian Neoplasms
5
Fallopian Tube Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Neoplasms
2
Lung Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Solid Tumors
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liver Neoplasms
1
HER2-negative Breast Cancer
1
Gastric Adenocarcinoma
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Small Cell
1
Breast Diseases
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
Gemcitabine
61
Cisplatin
39
Oxaliplatin
31
Capecitabine
29
Fluorouracil
22
Leucovorin
20
Irinotecan
12
pembrolizumab
11
130-nm albumin-bound paclitaxel
10
durvalumab
9
Erlotinib Hydrochloride
8
Trastuzumab
7
Bevacizumab
7
Taxes
6
Platinum
6
Magnetic Resonance Spectroscopy
6
Biopsy
6
Albumin-Bound Paclitaxel
6
1,2-diaminocyclohexaneplatinum II citrate
6
Specimen Handling
5
Sorafenib
5
Radiotherapy
5
Docetaxel
5
Carboplatin
5
Immunohistochemistry
4
trifluridine tipiracil drug combination
3
dehydroftorafur
3
atezolizumab
3
Watchful Waiting
3
Tegafur
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
taxane
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled